Copyright Reports & Markets. All rights reserved.

Global Ranibizumab Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Ranibizumab by Type
    • 1.3.1 Overview: Global Ranibizumab Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Ranibizumab Consumption Value Market Share by Type in 2023
    • 1.3.3 Glass Vial
    • 1.3.4 Prefilled Syringe
  • 1.4 Global Ranibizumab Market by Application
    • 1.4.1 Overview: Global Ranibizumab Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Wet AMD
    • 1.4.3 Complications of Diabetes
    • 1.4.4 RVO
    • 1.4.5 Others
  • 1.5 Global Ranibizumab Market Size & Forecast
  • 1.6 Global Ranibizumab Market Size and Forecast by Region
    • 1.6.1 Global Ranibizumab Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Ranibizumab Market Size by Region, (2019-2030)
    • 1.6.3 North America Ranibizumab Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Ranibizumab Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Ranibizumab Market Size and Prospect (2019-2030)
    • 1.6.6 South America Ranibizumab Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Ranibizumab Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Ranibizumab Product and Solutions
    • 2.1.4 Roche Ranibizumab Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Ranibizumab Product and Solutions
    • 2.2.4 Novartis Ranibizumab Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Novartis Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Ranibizumab Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Ranibizumab by Company Revenue
    • 3.2.2 Top 3 Ranibizumab Players Market Share in 2023
    • 3.2.3 Top 6 Ranibizumab Players Market Share in 2023
  • 3.3 Ranibizumab Market: Overall Company Footprint Analysis
    • 3.3.1 Ranibizumab Market: Region Footprint
    • 3.3.2 Ranibizumab Market: Company Product Type Footprint
    • 3.3.3 Ranibizumab Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Ranibizumab Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Ranibizumab Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Ranibizumab Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Ranibizumab Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Ranibizumab Consumption Value by Type (2019-2030)
  • 6.2 North America Ranibizumab Market Size by Application (2019-2030)
  • 6.3 North America Ranibizumab Market Size by Country
    • 6.3.1 North America Ranibizumab Consumption Value by Country (2019-2030)
    • 6.3.2 United States Ranibizumab Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Ranibizumab Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Ranibizumab Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Ranibizumab Consumption Value by Type (2019-2030)
  • 7.2 Europe Ranibizumab Consumption Value by Application (2019-2030)
  • 7.3 Europe Ranibizumab Market Size by Country
    • 7.3.1 Europe Ranibizumab Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Ranibizumab Market Size and Forecast (2019-2030)
    • 7.3.3 France Ranibizumab Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Ranibizumab Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Ranibizumab Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Ranibizumab Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Ranibizumab Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Ranibizumab Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Ranibizumab Market Size by Region
    • 8.3.1 Asia-Pacific Ranibizumab Consumption Value by Region (2019-2030)
    • 8.3.2 China Ranibizumab Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Ranibizumab Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Ranibizumab Market Size and Forecast (2019-2030)
    • 8.3.5 India Ranibizumab Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Ranibizumab Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Ranibizumab Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Ranibizumab Consumption Value by Type (2019-2030)
  • 9.2 South America Ranibizumab Consumption Value by Application (2019-2030)
  • 9.3 South America Ranibizumab Market Size by Country
    • 9.3.1 South America Ranibizumab Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Ranibizumab Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Ranibizumab Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Ranibizumab Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Ranibizumab Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Ranibizumab Market Size by Country
    • 10.3.1 Middle East & Africa Ranibizumab Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Ranibizumab Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Ranibizumab Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Ranibizumab Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Ranibizumab Market Drivers
  • 11.2 Ranibizumab Market Restraints
  • 11.3 Ranibizumab Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Ranibizumab Industry Chain
  • 12.2 Ranibizumab Upstream Analysis
  • 12.3 Ranibizumab Midstream Analysis
  • 12.4 Ranibizumab Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.
    According to our (Global Info Research) latest study, the global Ranibizumab market size was valued at US$ 3168 million in 2023 and is forecast to a readjusted size of USD 1568 million by 2030 with a CAGR of -9.7% during review period.
    Global core ranibizumab manufacturers include Roche and Novartis etc. The Top 2 companies hold a share about 98%. North America is the largest market, with a share about 51%, followed by Europe and Asia Pacific with the share about 28% and 20%.
    This report is a detailed and comprehensive analysis for global Ranibizumab market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Ranibizumab market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Ranibizumab market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Ranibizumab market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Ranibizumab market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ranibizumab
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ranibizumab market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Ranibizumab market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Ranibizumab market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Glass Vial
    Prefilled Syringe
    Market segment by Application
    Wet AMD
    Complications of Diabetes
    RVO
    Others
    Market segment by players, this report covers
    Roche
    Novartis
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Ranibizumab product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Ranibizumab, with revenue, gross margin, and global market share of Ranibizumab from 2019 to 2024.
    Chapter 3, the Ranibizumab competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Ranibizumab market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Ranibizumab.
    Chapter 13, to describe Ranibizumab research findings and conclusion.

    Buy now